In the high-risk world of drug development, meaningful benchmarks are your safeguard.
How Pharmapremia can help:
- Quickly assess the past drug successes and failures that most accurately reflect your portfolio candidates, eliminating weeks of reviewing multiple sources and compiling data piecemeal.
- Generate customized intelligence reports tailored to your company’s goals and challenges.
- Pharmapremia covers over 7,000 programs, including over 2,200 in oncology, over 1,100 in orphan diseases, and over 500 indications.
- Visually represent data to drive meaningful, data-centric discussion, rather than relying on qualitative and subjective opinion.
- Effectively manage your portfolio risk by accessing comprehensive data sets including:
- Probability of Overall Success (POS)
- Likelihood of Approval (LOA)
- Phase and Overall Duration
- Tap into Informa’s broad array of data: trial data, approval statistics, pipelines, deals, and more, to identify opportunities for and threats to your business.
- Trust the data you’re viewing by relying on the peer-reviewed drug success rate methodology featured in Nature Biotechnology and presented at Bio International.
Take your portfolio to the next level with Pharmapremia. Click the button above to schedule your demo today.